Biotecnología

Biotecnología

Avectas Expands Collaboration with CCRM and OmniaBio Inc.
30/11/2022 - Will enable the development of gene-edited induced pluripotent stem cells using Avectas' non-viral cell engineering platform, SOLUPORE.
Resolution Therapeutics and CCRM Enter Research Collaboration
15/11/2022 - Will develop and scale up manufacturing for induced pluripotent stem cell (iPSC)-derived macrophage cell therapies.
Predicting Stem Cell Activity to Ensure Safe and Effective Therapies
03/11/2022 - Predicting Stem Cell Activity to Ensure Safe and Effective Therapies
Cellusion, Minaris Enter LOI for Manufacturing Process for Cell Therapy
13/10/2022 - Will develop the manufacturing process of Cellusion’s leading program, CLS001, a novel regenerative medicine product for bullous keratopathy treatment.
Astellas Pharma and Pantherna Therapeutics Enter New Technology Evaluation Agreement
12/10/2022 - Pantherna's mRNA platform & Astellas' drug discovery capabilities will be combined to generate mRNA-based regenerative medicine programs.
Fujifilm Cellular Dynamics Names Ilyas Singeç as CSO
20/09/2022 - Previously served as the inaugural director of the Stem Cell Translation Laboratory.
$150 Million Gift Takes Stem Cell Research to New Heights
07/09/2022 - Noted businessman and philanthropist T. Denny Sanford has committed $150 million in new funding to expand and, in some ways, quite literally launch stem cell research and regenerative medicine at...
bluebird bio Wins FDA Approval of ZYNTEGLO
22/08/2022 - Becomes the first gene therapy for people with Beta-Thalassemia who require regular red blood cell transfusions.
Vertex to Acquire ViaCyte for $320M
12/07/2022 - Provides assets, capabilities and technologies including additional human stem cell lines, stem cell differentiation IP, and GMP manufacturing facilities.
Un pez biohíbrido nada con células cardiacas humanas
23/06/2022 - Los sistemas biohíbridos –dispositivos que contienen componentes biológicos y artificiales– ayudan a investigar la fisiología de los organismos vivos y...
AffyXell Expands Manufacturing Partnership with GenScript ProBio
19/05/2022 - Will develop next generation cell and gene therapies based on mesenchymal stem cells which incorporate Affimer immunotherapies.
Pluristyx and Accelerated Biosciences Enter Clinical Manufacturing Partnership
29/04/2022 - CDMO Pluristyx to make clinical grade human trophoblast stem cells (hTSCs) banks.
Genetic regulation of blood cells: Proximity of a gene to a genetic change plays an important role
26/04/2022 - Researchers have gained significant new insight into the genetic regulation of blood cells. They achieved this by analyzing a dataset that included more than 31,000 study participants, to date the...
Researchers improve optical tissue clearing method to diagnose cancer
22/04/2022 - The ability to visualize cancerous tumors and metastatic tissue three dimensionally (3D) can help clinicians diagnose the precise type and stage of cancer, while also informing the best treatment...
Promega and Fujifilm Cellular Dynamics Enter Assay Development Partnership
11/03/2022 - New licensing agreement will deliver luminescent reporter technology into iPSCs.
Cuando lo imposible se vuelve inevitable: la búsqueda de carne cultivada sin suero
16/02/2022 - Durante años, los críticos han argumentado que la supuesta indispensabilidad de FBS hizo que la carne cultivada a escala comercial no fuera un buen comienzo. Hoy en día, las...
UC San Diego Sends Blood Stem Cells to Space
27/12/2021 - Researchers at the University of California San Diego launched blood stem cells into space aboard a SpaceX Falcon 9 rocket to study stress-induced aging and how stem cells and their progeny transform...
State Stem Cell Agency Awards $4M for Blood Cancer Immunotherapy at UC San Diego
25/11/2021 - The California Institute for Regenerative Medicine (CIRM) approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen...
Envigo, Biocytogen Enter Mouse Model Research Pact
30/09/2021 - B-NDG Triple Immunodeficient model is used in research and drug discovery in oncology, immuno-oncology, infectious disease, and stem cell biology.
Good Food Institute ofrece financiación pública masiva para la I + D de proteínas alternativas
28/09/2021 - Good Food Institute calls for massive public funding into alternative proteins R&D Addressing the lack of public investment in the alternative proteins space, the Good Food Institute...
Brain Organoids Mimic Head Size Changes Associated with Type of Autism
31/08/2021 - Stem cell models derived from people with specific genomic variation recapitulate aspects of their autism spectrum disorder, providing a valuable model to study the condition and look for therapeutic...